RBC Bioscience (ROCO:6848) Accounts Payable: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6848 RBC Bioscience Corp ROCO:6848
75 GF Score
Price NT$18.90
GF Value NT$19.98
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is RBC Bioscience Accounts Payable?

RBC Bioscience ROCO:6848 -0.79% 75 Accounts Payable is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6848 with a GF Score™ of 75/100 and a GF Value™ of NT$19.98 (Fairly Valued). The stock has 7 warning signs investors should review.

RBC Bioscience's Accounts Payable for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

RBC Bioscience Accounts Payable Related Terms

RBC Bioscience Accounts Payable Historical Data

* Premium members only.

The historical data trend for RBC Bioscience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience Accounts Payable Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBC Bioscience Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6848
75GF Score
RBC Bioscience Corp ROCO:6848
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RBC Bioscience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$0.0 Mil mean?
RBC Bioscience (ROCO:6848) has a Accounts Payable of NT$0.0 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RBC Bioscience and its competitors.
Is RBC Bioscience's Accounts Payable too high?
RBC Bioscience's current Accounts Payable is NT$0.0 Mil. Overall, RBC Bioscience has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RBC Bioscience's Accounts Payable compare to VRTX and REGN?
RBC Bioscience's Accounts Payable of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on RBC Bioscience and its competitors. RBC Bioscience's current Accounts Payable is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Bioscience stock overvalued right now?
Based on GuruFocus' analysis, RBC Bioscience (ROCO:6848) is currently considered Fairly Valued. The stock's GF Value™ is NT$19.98, compared to a current price of NT$18.90 — trading 5.4% below its estimated fair value. The current Accounts Payable is NT$0.0 Mil. RBC Bioscience's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For RBC Bioscience (ROCO:6848), the current Accounts Payable is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RBC Bioscience (ROCO:6848) Overvalued in 2026?

Based on GuruFocus' analysis, RBC Bioscience stock appears to be undervalued. The current stock price of NT$18.90 is trading 5.4% below its estimated GF Value™ of NT$19.98. GuruFocus considers RBC Bioscience to be Fairly Valued.

Key valuation signals for ROCO:6848:

  • Accounts Payable: NT$0.0 Mil
  • GF Value™: NT$19.98 vs. price of NT$18.90 (5.4% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6848 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RBC Bioscience Business Description

Address No. 15, Qiaohe Road, 15th Floor, Zhonghe District, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.
75GF Score

Get the complete analysis for ROCO:6848

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.90
Price
NT$19.98
GF Value